Patents by Inventor Hyo-jung Song

Hyo-jung Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11837716
    Abstract: An electrode assembly for a rechargeable lithium battery and a rechargeable lithium battery including the same are disclosed. The electrode assembly for the rechargeable lithium battery includes: a negative electrode including a current collector; a negative active material layer; an organic-inorganic composite layer integrated with the negative active material layer, the negative active material layer including an organic layer and an inorganic layer; and a positive electrode, the negative active material layer including a first layer physically contacting the current collector, the first layer including a first carbon-based negative active material, and a second layer on the first layer, including a second carbon-based negative active material, wherein a DD value of the first layer is about 30% to about 90% of a DD value of the negative active material layer, and the DD values are defined by Equation 1.
    Type: Grant
    Filed: August 26, 2021
    Date of Patent: December 5, 2023
    Assignee: Samsung SDI Co., Ltd.
    Inventors: Hyo-Jung Song, Jinhyon Lee
  • Publication number: 20230317960
    Abstract: The present invention relates to an electrode assembly for a lithium secondary battery and a lithium secondary battery including the same, the electrode assembly comprising: a current collector, a negative electrode comprising a negative electrode active material layer located on the current collector and an organic-inorganic composite layer integrated with the negative electrode active material layer, and a positive electrode, wherein the organic-inorganic composite layer comprises an organic layer and an inorganic layer.
    Type: Application
    Filed: August 26, 2021
    Publication date: October 5, 2023
    Inventors: Mihwa YANG, Junghyun NAM, Hyo-jung SONG, Hyejin YOON, Jinhee LEE
  • Publication number: 20230290958
    Abstract: The present invention relates to an electrode assembly for a lithium secondary battery, and a lithium secondary battery comprising same, the electrode assembly comprising a current collector, an anode comprising an anode active material layer located on the current collector and a functional layer integrated with the anode active material layer; and a cathode, wherein the functional layer includes at least one inorganic layer and the peel strength of the functional layer is 0.2 N/m or greater.
    Type: Application
    Filed: February 21, 2022
    Publication date: September 14, 2023
    Inventors: Jinhee LEE, Junghyun NAM, Hyo-jung SONG, Mihwa YANG, Hyejin YOON
  • Publication number: 20230270868
    Abstract: The present invention relates to a pyrrolobenzodiazepine dimer prodrug and a ligand-linker conjugate compound thereof, a composition containing these, and therapeutic use thereof particularly as an anticancer drug. The stability of the compounds themselves and the stability thereof in plasma are excellent and the compounds are advantageous in terms of manifestation of toxicity, and thus the compounds are industrially useful in that it is possible to target proliferative diseases such as cancer, to perform a specific treatment, to maximize the drug efficacy, and to minimize the occurrence of side effects.
    Type: Application
    Filed: February 24, 2023
    Publication date: August 31, 2023
    Inventors: Ho Young Song, Sung Min Kim, Hyoungrae Kim, Kyung Eun Park, Chul-Woong Chung, Yun-Hee Park, Hyo Jung Choi, Su In Lee, Juyuel Baek, Hyeun Joung Lee, Ju Young Lee, Ji Hye Oh, Jeiwook Chae, Yeong Soo Oh, Yong Zu Kim
  • Patent number: 11731961
    Abstract: Compounds of Formula (I), racemates, enantiomers, diastereomers thereof or pharmaceutical acceptable salts thereof, or pharmaceutical compositions containing the compounds, racemates, enantiomers, diastereomers thereof are disclosed. These compounds have GPR40 agonist activity and are capable of modulating blood glucose levels and glucose-dependent insulin secretion mechanism, and, thus, exhibit excellent glucose lowering efficacy without the risk of hypoglycemia. These compounds could be used in preventing and/or treating type 2 diabetes through adequate control of blood glucose.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: August 22, 2023
    Assignee: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Jae-Hoon Kang, Hong-Sub Lee, Kyung-Mi An, Chang-Hee Hong, Hyun-Jung Kwak, Shuo-Lin Cui, Hyo-Jung Song
  • Publication number: 20230246200
    Abstract: An electrode including a current collector; an electrode active material layer on a surface of the current collector and including internal pores; an inner coating layer filled in the internal pores of the electrode active material layer and including an adhesive material; and an outer coating layer disposed on a surface of the electrode active material layer and including an adhesive material. A total weight of the inner coating layer and the outer coating layer per area of one surface of the current collector is about 0.1 g/m2 to about 0.7 g/m2. In addition, the electrode active material layer has a porosity of about 13% to about 16% in a cross section having a depth of about 20 ?m from the surface of the electrode active material layer to the current collector.
    Type: Application
    Filed: January 24, 2023
    Publication date: August 3, 2023
    Inventors: Jinhee LEE, Hyo-jung SONG, Minjae KIM, Mihwa YANG, Kyoseon KOO, Jeunggi MOON, Duckjae YOU
  • Patent number: 11654197
    Abstract: The present disclosure relates to pyrrolobenzodiazepine dimer prodrugs and ligand-linker conjugates thereof. The present disclosure also relates to compositions and uses of said prodrugs and conjugates.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: May 23, 2023
    Assignee: LegoChem Biosciences, Inc.
    Inventors: Ho Young Song, Sung Min Kim, Hyoungrae Kim, Kyung Eun Park, Chul-Woong Chung, Yun Hee Park, Hyo Jung Choi, Su In Lee, Juyuel Baek, Hyeun Joung Lee, Ju Young Lee, Ji Hye Oh, Jeiwook Chae, Yeong Soo Oh, Yong Zu Kim
  • Publication number: 20230122856
    Abstract: An electrode assembly and a rechargeable lithium battery including the same are disclosed herein. The electrode assembly includes an electrode and a separator, wherein the electrode includes a current collector, an electrode active material layer on the current collector, and an adhesive layer on the electrode active material layer; and wherein the separator has a larger surface area than the adhesive layer of the electrode; and a surface of the separator opposing the adhesive layer of the electrode is divided into an adhesive region in contact with the adhesive layer of the electrode and an overhang region not in contact with the adhesive layer of the electrode.
    Type: Application
    Filed: October 14, 2022
    Publication date: April 20, 2023
    Inventors: Hyo-jung SONG, Kyoseon KOO, Minjae KIM, Junghyun NAM, Jeunggi MOON, Mihwa YANG, Duckjae YOU, Jinhee LEE
  • Publication number: 20230122468
    Abstract: Disclosed are a negative electrode for a rechargeable lithium battery and a rechargeable lithium battery including the same, the negative electrode including a current collector, a negative active material layer on the current collector, including a silicon-based negative active material, and an adhesive layer on the negative active material layer, wherein the adhesive layer has a thickness of about 5 ?m or less, the adhesive layer has an area of about 50 area % based on the total area of the negative active material layer, and the adhesive layer is positioned in a dot pattern.
    Type: Application
    Filed: October 10, 2022
    Publication date: April 20, 2023
    Inventors: Minjae KIM, Kyoseon KOO, Junghyun NAM, Jeunggi MOON, Hyo-jung SONG, Mihwa YANG, Duckjae YOU, Jinhee LEE, Sungsoo HAN
  • Publication number: 20220112185
    Abstract: Compounds of Formula (I), racemates, enantiomers, diastereomers thereof or pharmaceutical acceptable salts thereof, or pharmaceutical compositions containing the compounds, racemates, enantiomers, diastereomers thereof, and a manufacturing method thereof are disclosed. These compounds have GPR40 agonist activity and are capable of modulating blood glucose levels and glucose-dependent insulin secretion mechanism, and, thus, exhibit excellent glucose lowering efficacy without the risk of hypoglycemia. These compounds could be used in preventing and/or treating type 2 diabetes through adequate control of blood glucose.
    Type: Application
    Filed: December 22, 2021
    Publication date: April 14, 2022
    Applicant: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Jae-Hoon KANG, Hong-Sub LEE, Kyung-Mi AN, Chang-Hee HONG, Hyun-Jung KWAK, Shuo-Lin CUI, Hyo-Jung SONG
  • Publication number: 20220069293
    Abstract: An electrode assembly for a rechargeable lithium battery and a rechargeable lithium battery including the same are disclosed. The electrode assembly for the rechargeable lithium battery includes: a negative electrode including a current collector; a negative active material layer; an organic-inorganic composite layer integrated with the negative active material layer, the negative active material layer including an organic layer and an inorganic layer; and a positive electrode, the negative active material layer including a first layer physically contacting the current collector, the first layer including a first carbon-based negative active material, and a second layer on the first layer, including a second carbon-based negative active material, wherein a DD value of the first layer is about 30% to about 90% of a DD value of the negative active material layer, and the DD values are defined by Equation 1.
    Type: Application
    Filed: August 26, 2021
    Publication date: March 3, 2022
    Inventors: Hyo-jung SONG, Jinhyon LEE
  • Publication number: 20220064154
    Abstract: Compounds of Formula (I), racemates, enantiomers, diastereomers thereof or pharmaceutical acceptable salts thereof, or pharmaceutical compositions containing the compounds, racemates, enantiomers, diastereomers thereof are disclosed. These compounds have GPR40 agonist activity and are capable of modulating blood glucose levels and glucose-dependent insulin secretion mechanism, and, thus, exhibit excellent glucose lowering efficacy without the risk of hypoglycemia. These compounds could be used in preventing and/or treating type 2 diabetes through adequate control of blood glucose.
    Type: Application
    Filed: November 10, 2021
    Publication date: March 3, 2022
    Applicant: ILDONG PHARMACEUTICAL CO, LTD.
    Inventors: Jae-Hoon KANG, Hong-Sub LEE, Kyung-Mi AN, Chang-Hee HONG, Hyun-Jung KWAK, Shuo-Lin CUI, Hyo-Jung SONG
  • Patent number: 11225472
    Abstract: The present invention relates to the compounds according to Formula (I), the racemates, enantiomers, diastereomers thereof or pharmaceutical acceptable salts thereof, or pharmaceutical compositions comprising these, for the treatment or prevention of metabolic disorders. The compounds according to Formula (I) are, as GPR40 agonists, available for oral administration with glucose-dependent insulin secretion mechanism, which exhibit excellent glucose lowering efficacy without the risk of hypoglycemia. Thus, the compounds and/or pharmaceutical compositions comprising the compounds as effective components are useful in treating and/or preventing symptoms of type 2 diabetes through adequate control of blood glucose.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: January 18, 2022
    Inventors: Jae-Hoon Kang, Hong-Sub Lee, Kyung-Mi An, Chang-Hee Hong, Hyun-Jung Kwak, Shuo-Lin Cui, Hyo-Jung Song
  • Patent number: 11053190
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: July 6, 2021
    Assignee: NeuroBiogen Co., Ltd.
    Inventors: Ki Duk Park, ChangJoon Justin Lee, Dong Jin Kim, Ae Nim Pae, Hyun Ah Choo, Sun Joon Min, Yong Koo Kang, Yun Kyung Kim, Hyo Jung Song, Ji Won Choi, Min Ho Nam, Jun Young Heo, Seul Ki Yeon, Bo Ko Jang, Eun Ji Ju, Seon Mi Jo, Jong-Hyun Park
  • Patent number: 10978697
    Abstract: Disclosed are a negative active material for a rechargeable lithium battery and a rechargeable lithium battery including the same. The negative active material has an N/P ratio, which is a ratio of a maximum capacity per a unit area of a negative active material relative to maximum capacity per a unit area of a positive active material, ranging from about 1.5 to about 2. The negative active material includes a composite particle of silicon (Si) and carbon and crystalline carbon. A content of the Si is about 3 wt % to about 15 wt % based on a total weight of the negative active material.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: April 13, 2021
    Assignee: SAMSUNG SDI CO., LTD.
    Inventors: Dong-Ho Son, Kijun Kim, Hyo-Jung Song, Suyoun Yoon
  • Publication number: 20200308104
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.
    Type: Application
    Filed: April 24, 2020
    Publication date: October 1, 2020
    Inventors: Ki Duk PARK, ChangJoon Justin LEE, Dong Jin KIM, Ae Nim PAE, Hyun Ah CHOO, Sun Joon MIN, Yong Koo KANG, Yun Kyung KIM, Hyo Jung SONG, Ji Won CHOI, Min Ho NAM, Jun Young HEO, Seul Ki YEON, Bo Ko JANG, Eun Ji JU, Seon Mi JO, Jong-Hyun PARK
  • Publication number: 20200223833
    Abstract: The present invention relates to the compounds according to Formula (1), the racemates, enantiomers, diastereomers thereof or pharmaceutical acceptable salts thereof, or pharmaceutical compositions comprising these, for the treatment or prevention of metabolic disorders. The compounds according to Formula (1) are, as GPR40 agonists, available for oral administration with glucose-dependent insulin secretion mechanism, which exhibit excellent glucose lowering efficacy without the risk of hypoglycemia. Thus, the compounds and/or pharmaceutical compositions comprising the compounds as effective components are useful in treating and/or preventing symptoms of type 2 diabetes through adequate control of blood glucose.
    Type: Application
    Filed: December 14, 2017
    Publication date: July 16, 2020
    Inventors: Jae-Hoon Kang, Hong-Sub Lee, Kyung-Mi An, Chang-Hee Hong, Hyun-Jung Kwak, Shuo-Lin Cui, Hyo-Jung Song
  • Patent number: 10676425
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same, for treating a neurodegenerative diseases.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: June 9, 2020
    Assignee: MEGABIOWOOD CO., LTD
    Inventors: Ki Duk Park, ChangJoon Justin Lee, Dong Jin Kim, Ae Nim Pae, Hyun Ah Choo, Sun Joon Min, Yong Koo Kang, Yun Kyung Kim, Hyo Jung Song, Ji Won Choi, Min Ho Nam, Jun Young Heo, Seul Ki Yeon, Bo Ko Jang, Eun Ji Ju, Seon Mi Jo, Jong-Hyun Park
  • Publication number: 20200067078
    Abstract: Disclosed are a negative active material for a rechargeable lithium battery and a rechargeable lithium battery including the same. The negative active material has an N/P ratio, which is a ratio of a maximum capacity per a unit area of a negative active material relative to maximum capacity per a unit area of a positive active material, ranging from about 1.5 to about 2. The negative active material includes a composite particle of silicon (Si) and carbon and crystalline carbon. A content of the Si is about 3 wt % to about 15 wt % based on a total weight of the negative active material.
    Type: Application
    Filed: August 14, 2019
    Publication date: February 27, 2020
    Inventors: Dong-Ho SON, Kijun KIM, Hyo-jung SONG, Suyoun YOON
  • Publication number: 20170298011
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.
    Type: Application
    Filed: September 24, 2015
    Publication date: October 19, 2017
    Inventors: Ki Duk PARK, ChangJoon Justin LEE, Dong Jin KIM, Ae Nim PAE, Hyun Ah CHOO, Sun Joon MIN, Yong Koo KANG, Yun Kyung KIM, Hyo Jung SONG, Ji Won CHOI, Min Ho NAM, Jun Young HEO, Seul Ki YEON, Bo Ko JANG, Eun Ji JU, Seon Mi JO, Jong-Hyun PARK